Clinical Trials Directory

Trials / Suspended

SuspendedNCT06998355

BE.Amycon Registry UZ Leuven

BE.Amycon Amyloidosis Data Registry UZ Leuven

Status
Suspended
Phase
Study type
Observational
Enrollment
550 (estimated)
Sponsor
Universitaire Ziekenhuizen KU Leuven · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The goal of this observational study is to establish database with (limited) personal and health data of patients diagnosed with amyloidosis (any subtype) in order to get better insights on the disease presentation, disease evolution pattern, treatment plans and responses and survival.

Detailed description

With the support of VIB Grand Challenges Program, this project aims to establish the BElgian AMYloidosis CONsortium (BE.AMYCON) by joining forces of VIB researchers, a state-of-the-art diagnostic platform, and clinicians from various disciplines and different institutes. Such a consortium will address patient needs and improve outcomes on many levels. In this context, a registry of clinical data is a requirement for both improvement of diagnostics as well as fundamental research purposes.

Conditions

Interventions

TypeNameDescription
OTHERRegistryobservational data collection

Timeline

Start date
2025-09-01
Primary completion
2027-12-31
Completion
2028-06-01
First posted
2025-05-31
Last updated
2025-08-28

Locations

1 site across 1 country: Belgium

Source: ClinicalTrials.gov record NCT06998355. Inclusion in this directory is not an endorsement.